Skip to main content
Log in

Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease

  • Short Report
  • Published:
Journal of Inherited Metabolic Disease

Summary

Copper-histidine is the treatment of choice in Menkes disease but bears the potential risk of copper overload and induced liver cirrhosis. We report normal copper concentrations of liver tissue over an 8-year treatment period with copper-histidine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Plecko.

Additional information

Communicating editor: Verena Peters

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kroepfl, T., Mair, E., Deutsch, J. et al. Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease. J Inherit Metab Dis 29, 593 (2006). https://doi.org/10.1007/s10545-006-0312-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-006-0312-1

Keywords

Navigation